Taniguchi Masaru, Harada Michishige, Kojo Satoshi, Nakayama Toshinori, Wakao Hiroshi
Laboratory of Immune Regulation, RIKEN Research Center for Allergy and Immunology, Chuo-ku, Chiba 260-8670, Japan.
Annu Rev Immunol. 2003;21:483-513. doi: 10.1146/annurev.immunol.21.120601.141057. Epub 2001 Dec 19.
A novel lymphocyte lineage, Valpha14 natural killer T (NKT) cells, is now well established as distinct from conventional alphabeta T cells. Valpha14 NKT cells express a single invariant Valpha14 antigen receptor that is essential for their development. Successful identification of a specific ligand, alpha-galactosylceramide(alpha-GalCer), and the establishment of gene-manipulated mice with selective loss of Valpha14 NKT cells helped elucidate the remarkable functional diversity of Valpha14 NKT cells in various immune responses such as host defense by mediating anti-nonself innate immune reaction, homeostatic regulation of anti-self responses, and antitumor immunity.
一种新型淋巴细胞谱系,即Vα14自然杀伤T(NKT)细胞,现已明确与传统的αβ T细胞不同。Vα14 NKT细胞表达单一恒定的Vα14抗原受体,这对其发育至关重要。成功鉴定出特异性配体α-半乳糖神经酰胺(α-GalCer),以及建立Vα14 NKT细胞选择性缺失的基因操作小鼠,有助于阐明Vα14 NKT细胞在各种免疫反应中的显著功能多样性,如通过介导抗非己固有免疫反应进行宿主防御、抗自身反应的稳态调节以及抗肿瘤免疫。